[go: up one dir, main page]

HK40083219A - Coronavirus irna compositions and methods of use thereof - Google Patents

Coronavirus irna compositions and methods of use thereof Download PDF

Info

Publication number
HK40083219A
HK40083219A HK62023069970.9A HK62023069970A HK40083219A HK 40083219 A HK40083219 A HK 40083219A HK 62023069970 A HK62023069970 A HK 62023069970A HK 40083219 A HK40083219 A HK 40083219A
Authority
HK
Hong Kong
Prior art keywords
coronavirus
methods
irna compositions
irna
compositions
Prior art date
Application number
HK62023069970.9A
Other languages
Chinese (zh)
Inventor
Akin Akinc
James D. MCININCH
Yesseinia ANGLERO-RODRIGUEZ
Mark K. SCHLEGEL
Christy M. HEBNER
Florian A. LEMPP
Original Assignee
Alnylam Pharmaceuticals, Inc.
Vir Biotechnology, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alnylam Pharmaceuticals, Inc., Vir Biotechnology, Inc. filed Critical Alnylam Pharmaceuticals, Inc.
Publication of HK40083219A publication Critical patent/HK40083219A/en

Links

HK62023069970.9A 2020-03-26 2021-03-25 Coronavirus irna compositions and methods of use thereof HK40083219A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US62/994,907 2020-03-26
US63/001,580 2020-03-30
US63/019,481 2020-05-04
US63/124,910 2020-12-14

Publications (1)

Publication Number Publication Date
HK40083219A true HK40083219A (en) 2023-06-23

Family

ID=

Similar Documents

Publication Publication Date Title
EP4143196A4 (en) PI3K-a INHIBITORS AND METHODS OF USE THEREOF
EP4381022A4 (en) Compositions and methods of use thereof
EP4298076A4 (en) Ceramic compositions and methods of use
EP4054514A4 (en) Compositions containing fenchols and methods of use
CA3255793A1 (en) Angiotensinogen-modulating compositions and methods of use thereof
HK40083219A (en) Coronavirus irna compositions and methods of use thereof
CA3263050A1 (en) Compositions for targeted lysosomal degradaton and methods of use thereof
AU2021376143A9 (en) Hydrogel compositions and methods of use thereof
EP4240327A4 (en) Hydrogel compositions and methods of use thereof
IL312205A (en) Coxsackievirus b compositions and methods of use thereof
EP4308129A4 (en) Vaccine compositions and methods of use thereof
EP4084777A4 (en) Compositions containing exosome carrying nf-kb inhibitors and methods of using thereof
HK40114450A (en) Angiotensinogen-modulating compositions and methods of use thereof
HK40115640A (en) Prekallikrein-modulating compositions and methods of use thereof
HK40101479A (en) Compositions and methods of use thereof
HK40115145A (en) Angiotensinogen-modulating compositions and methods of use thereof
CA3290187A1 (en) Mivelsiran compositions and methods of use thereof
CA3289428A1 (en) Mapt-modulating compositions and methods of use thereof
CA3284058A1 (en) Compositions and methods of use thereof
CA3292256A1 (en) Sleep-improving compositions and methods of use
HK40109674A (en) Mirna-based compositions and methods of use thereof
EP4399529A4 (en) Biomarker compositions and methods of use thereof
HK40110424A (en) Collagen compositions and methods of use thereof
HK40109275A (en) Complement factor b (cfb) irna compositions and methods of use thereof
HK40107516A (en) Transposon compositions and methods of use thereof